Jenny O’Nions

1.8k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Jenny O’Nions is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Jenny O’Nions has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Hematology. Recurrent topics in Jenny O’Nions's work include Acute Myeloid Leukemia Research (9 papers), Cancer-related Molecular Pathways (7 papers) and Viral-associated cancers and disorders (6 papers). Jenny O’Nions is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Cancer-related Molecular Pathways (7 papers) and Viral-associated cancers and disorders (6 papers). Jenny O’Nions collaborates with scholars based in United Kingdom, Australia and United States. Jenny O’Nions's co-authors include Martin J. Allday, Louise Brooks, Tim Crook, John Tidy, María C. Marín, William G. Kaelin, Catherine Harwood, John M. Nicholls, Jane McGregor and Karen H. Vousden and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Jenny O’Nions

26 papers receiving 1.1k citations

Hit Papers

A common polymorphism acts as an intragenic modifier of m... 2000 2026 2008 2017 2000 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
    2000 442 citations María C. Marín, Christine A. Jost et al. Nature Genetics profile →

Peers

Jenny O’Nions
Robert E. Sobol United States
Laura K. Aguilar United States
Maaret Ridanpää Finland
Ranjani Rajapaksa United States
Hiep Phuc Dong Norway
Andras Heczey United States
Julian Schardt Switzerland
Joan de Jong Netherlands
Rena Morita Japan
Walter Hanel United States
Robert E. Sobol United States
Jenny O’Nions
Citations per year, relative to Jenny O’Nions Jenny O’Nions (= 1×) peers Robert E. Sobol

Countries citing papers authored by Jenny O’Nions

Since Specialization
Citations

This map shows the geographic impact of Jenny O’Nions's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny O’Nions with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny O’Nions more than expected).

Fields of papers citing papers by Jenny O’Nions

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny O’Nions. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny O’Nions. The network helps show where Jenny O’Nions may publish in the future.

Co-authorship network of co-authors of Jenny O’Nions

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny O’Nions. A scholar is included among the top collaborators of Jenny O’Nions based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny O’Nions. Jenny O’Nions is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ke, et al.. (2025). Diagnosis and treatment of T/myeloid mixed phenotype acute leukaemia (T/M‐MPAL). eJHaem. 6(1). e1075–e1075.
2.
Loo, Sun, Nicola Potter, Adam Ivey, et al.. (2024). Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia. Blood. 144(24). 2554–2557. 4 indexed citations
3.
Nacheva, Elisabeth P., et al.. (2023). P574: DIAGNOSIS AND TREATMENT OF T/MYELOID MIXED PHENOTYPE ACUTE LEUKAEMIA (T/M-MPAL)- A UK SINGLE CENTRE EXPERIENCE. HemaSphere. 7(S3). e11580ad–e11580ad. 1 indexed citations
4.
Alimam, Samah, Donal P. McLornan, John A. Henry, et al.. (2023). Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’. Current Research in Translational Medicine. 72(1). 103420–103420. 5 indexed citations
5.
6.
Taussig, David, Jenny O’Nions, Mojca Jongen‐Lavrencic, et al.. (2022). EP0042, a Dual FLT3 and Aurora Kinase Inhibitor: Preliminary Results of an Ongoing Phase I/IIa First in Human Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Blood. 140(Supplement 1). 6222–6223. 1 indexed citations
7.
Wilson, Andrew J., et al.. (2021). Single Centre Analysis of JAK2 V617F and Exon 12 Negative Idiopathic Erythrocytosis. Blood. 138(Supplement 1). 4620–4620. 2 indexed citations
8.
9.
10.
O’Nions, Jenny, et al.. (2013). A complex neurological presentation of syphilis. BMJ Case Reports. 2013. bcr2013200309–bcr2013200309. 6 indexed citations
11.
12.
Syed, Nelofer, Paul J. Smith, Alexandra Sullivan, et al.. (2005). Transcriptional silencing of Polo-like kinase 2(SNK/PLK2)is a frequent event in B-cell malignancies. Blood. 107(1). 250–256. 94 indexed citations
13.
O’Nions, Jenny & Martin J. Allday. (2004). Deregulation of the Cell Cycle by the Epstein–Barr Virus. Advances in cancer research. 92. 119–186. 24 indexed citations
14.
O’Nions, Jenny & Martin J. Allday. (2004). Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein–Barr virus or T cell-derived mitogens. Journal of General Virology. 85(4). 881–895. 25 indexed citations
15.
O’Nions, Jenny & Martin J. Allday. (2003). Epstein–Barr virus can inhibit genotoxin-induced G1 arrest downstream of p53 by preventing the inactivation of CDK2. Oncogene. 22(46). 7181–7191. 25 indexed citations
16.
McGregor, Jane, Catherine Harwood, Louise Brooks, et al.. (2002). Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer. Journal of Investigative Dermatology. 119(1). 84–90. 77 indexed citations
17.
Brooks, L., Alice Sullivan, Jenny O’Nions, et al.. (2002). E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. British Journal of Cancer. 86(2). 263–268. 27 indexed citations
18.
O’Nions, Jenny, L. Brooks, Alice Sullivan, et al.. (2001). p73 is over-expressed in vulval cancer principally as the Δ2 isoform. British Journal of Cancer. 85(10). 1551–1556. 46 indexed citations
19.
Crook, Tim, John M. Nicholls, Louise Brooks, Jenny O’Nions, & Martin J. Allday. (2000). High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?. Oncogene. 19(30). 3439–3444. 162 indexed citations
20.
Marín, María C., Christine A. Jost, Louise Brooks, et al.. (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nature Genetics. 25(1). 47–54. 442 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Sobol Breakdown of academic impact, for papers by Laura K. Aguilar Breakdown of academic impact, for papers by Maaret Ridanpää Breakdown of academic impact, for papers by Ranjani Rajapaksa Breakdown of academic impact, for papers by Hiep Phuc Dong Breakdown of academic impact, for papers by Andras Heczey Breakdown of academic impact, for papers by Julian Schardt Breakdown of academic impact, for papers by Joan de Jong Breakdown of academic impact, for papers by Rena Morita Breakdown of academic impact, for papers by Walter Hanel
Rankless by CCL
2026